— Know what they know.
Not Investment Advice

KRYS NASDAQ

Krystal Biotech, Inc.
1W: -3.8% 1M: +10.2% 3M: +16.2% YTD: +23.2% 1Y: +131.3% 3Y: +243.6% 5Y: +347.9%
$299.45
-4.78 (-1.57%)
 
Weekly Expected Move ±5.7%
$271 $289 $306 $324 $341
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 67 · $8.8B mcap · 23M float · 1.21% daily turnover · Short 81% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
55.7 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 48.4%  ·  5Y Avg: 17.5%
Cost Advantage
64
Intangibles
45
Switching Cost
73
Network Effect
47
Scale
42
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. KRYS has a Narrow competitive edge (55.7/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Switching Costs. ROIC of 48.4% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$300
Low
$300
Avg Target
$300
High
Based on 1 analyst since May 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 17Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$300.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-05 Evercore ISI $206 $300 +94 +2.0% $294.07
2026-02-18 Chardan Capital Geulah Livshits $216 $323 +107 +14.3% $282.65
2026-02-17 Jefferies Roger Song Initiated $371 +27.4% $291.10
2026-01-30 Goldman Sachs Initiated $327 +17.1% $279.34
2026-01-09 H.C. Wainwright Initiated $310 +24.5% $248.91
2025-10-17 Guggenheim Debjit Chattopadhyay Initiated $224 +18.9% $188.33
2025-08-22 Chardan Capital $133 $216 +83 +43.5% $150.49
2024-09-11 Stifel Nicolaus Dae Gon Ha $204 $220 +16 +18.9% $185.00
2024-09-02 Bank of America Securities Alec Stranahan Initiated $205 +5.1% $195.12
2024-08-12 Evercore ISI Gavin Clark-Gartner Initiated $206 +13.1% $182.17
2024-04-15 Stifel Nicolaus Dae Gon Ha Initiated $204 +20.2% $169.75
2022-11-07 Chardan Capital Geulah Livshits $130 $133 +3 +70.4% $78.05
2022-08-08 Chardan Capital Geulah Livshits Initiated $130 +57.8% $82.40

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
May 22, 2026
DCF
4
ROE
5
ROA
5
D/E
4
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. KRYS receives an overall rating of A-. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5), D/E (4/5). Areas of concern: P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-04 B+ A-
2026-04-01 A- B+
2026-03-09 B+ A-
2026-03-02 A- B+
2026-02-18 C+ A-
2026-02-17 A- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

86 Grade A+
Profitability
95
Balance Sheet
92
Earnings Quality
67
Growth
78
Value
41
Momentum
96
Safety
100
Cash Flow
94
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. KRYS scores highest in Safety (100/100) and lowest in Value (41/100). An overall grade of A+ places KRYS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
43.00
Safe Zone
Piotroski F-Score
8/9
Beneish M-Score
-2.37
Unlikely Manipulator
Ohlson O-Score
-14.90
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 94.2/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.11x
Accruals: -2.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. KRYS scores 43.00, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. KRYS scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. KRYS's score of -2.37 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. KRYS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. KRYS receives an estimated rating of AA+ (score: 94.2/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). KRYS's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
38.97x
PEG
0.49x
P/S
21.15x
P/B
6.87x
P/FCF
33.20x
P/OCF
31.49x
EV/EBITDA
38.08x
EV/Revenue
16.92x
EV/EBIT
39.50x
EV/FCF
29.75x
Earnings Yield
2.86%
FCF Yield
3.01%
Shareholder Yield
0.22%
Graham Number
$81.45
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 39.0x earnings, KRYS commands a growth premium. Graham's intrinsic value formula yields $81.45 per share, 268% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.085
NI / EBT
×
Interest Burden
1.159
EBT / EBIT
×
EBIT Margin
0.428
EBIT / Rev
×
Asset Turnover
0.349
Rev / Assets
×
Equity Multiplier
1.103
Assets / Equity
=
ROE
20.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. KRYS's ROE of 20.8% is driven by EBIT Margin (0.428) as the dominant factor. A tax burden ratio of 1.09 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
77.75%
Fair P/E
164.00x
Intrinsic Value
$1209.72
Price/Value
0.21x
Margin of Safety
78.65%
Premium
-78.65%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with KRYS's realized 77.7% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $1209.72, KRYS appears undervalued with a 79% margin of safety. The adjusted fair P/E of 164.0x compares to the current market P/E of 39.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$299.45
Median 1Y
$335.31
5th Pctile
$102.94
95th Pctile
$1097.04
Ann. Volatility
66.3%
Analyst Target
$300.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Krish S. Krishnan
Chair and Chief Executive Officer
$846,167 $4,104,825 $10,442,485
Suma M. Krishnan
President, R&D
$677,500 $2,868,000 $6,948,401
Kathryn A. Romano
Chief Accounting Officer
$437,500 $394,350 $2,258,697

CEO Pay Ratio

7470:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,442,485
Avg Employee Cost (SGA/emp): $1,398
Employees: 105,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
105,000
+38081.8% YoY
Revenue / Employee
$3,706
Rev: $389,130,000
Profit / Employee
$1,951
NI: $204,831,000
SGA / Employee
$1,398
Avg labor cost proxy
R&D / Employee
$553
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -21.1% -23.5% -15.7% -23.4% -26.1% -29.3% -25.1% -24.3% -25.2% -5.3% 1.7% 8.8% 16.3% 8.1% 10.3% 14.4% 17.0% 23.1% 18.9% 20.8% 20.78%
ROA -20.1% -22.4% -14.8% -22.1% -24.6% -27.7% -23.6% -22.8% -23.7% -5.0% 1.6% 8.3% 15.4% 7.6% 9.5% 13.2% 15.7% 21.2% 17.1% 18.8% 18.83%
ROIC -1.2% -1.4% -33.0% -38.2% -44.2% -51.8% -62.5% -74.7% -79.6% -76.7% -36.5% -25.7% -8.1% 9.8% 17.2% 27.4% 34.0% 47.3% 43.5% 48.4% 48.39%
ROCE -17.2% -19.2% -11.3% -17.3% -19.3% -22.0% -26.9% -24.3% -26.0% -25.0% -11.4% -6.1% 1.5% 9.2% 10.8% 14.0% 15.9% 17.3% 13.1% 14.5% 14.53%
Gross Margin 97.4% 89.6% 94.7% 91.5% 92.0% 94.6% 94.3% 92.5% 94.2% 89.8% 94.6% 94.57%
Operating Margin -3.0% 7.4% -14.8% 12.2% 26.8% 45.4% 41.0% 40.9% 42.3% 41.5% 46.1% 46.14%
Net Margin 9.4% 20.6% 2.1% 22.2% 32.4% 49.9% 40.5% 39.9% 81.2% 48.0% 48.1% 48.07%
EBITDA Margin -2.9% 28.9% 16.4% 32.8% 43.5% 47.1% 42.9% 42.5% 50.7% 37.0% 47.6% 47.62%
FCF Margin -13.9% -2.0% -56.7% -13.7% 24.0% 41.0% 38.8% 51.6% 44.4% 48.5% 56.9% 56.88%
OCF Margin -12.1% -1.8% -48.7% -10.1% 26.2% 42.5% 41.5% 54.4% 47.2% 51.6% 60.0% 59.97%
ROE 3Y Avg snapshot only 12.96%
ROE 5Y Avg snapshot only -0.90%
ROA 3Y Avg snapshot only 11.87%
ROIC Economic snapshot only 15.90%
Cash ROA snapshot only 18.76%
Cash ROIC snapshot only 62.40%
CROIC snapshot only 59.18%
NOPAT Margin snapshot only 46.51%
Pretax Margin snapshot only 49.68%
R&D / Revenue snapshot only 14.17%
SGA / Revenue snapshot only 37.15%
SBC / Revenue snapshot only 6.64%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -28.94 -19.94 -22.33 -16.11 -14.53 -13.76 -14.46 -15.21 -22.29 -112.42 327.03 91.18 51.37 103.93 52.51 43.45 27.87 26.48 36.05 35.02 38.974
P/S Ratio 391.71 70.52 54.32 32.74 22.54 16.11 16.15 11.38 14.11 18.98 18.88 21.154
P/B Ratio 5.17 3.97 2.62 2.82 2.83 3.01 3.88 3.94 5.99 6.42 4.59 6.69 6.99 6.99 4.95 5.69 4.32 5.56 6.05 6.46 6.869
P/FCF -28.80 -16.63 -13.36 -12.21 -9.20 -9.51 -13.18 -13.51 -24.11 -28.15 -35.54 -95.74 -239.16 93.75 39.28 41.65 22.05 31.80 39.09 33.20 33.198
P/OCF 85.93 37.93 38.89 20.93 29.89 36.76 31.49 31.487
EV/EBITDA -25.75 -16.60 -17.20 -12.35 -11.08 -10.57 -11.97 -13.59 -20.74 -23.44 -36.30 -112.66 272.52 62.16 37.22 34.18 22.14 27.32 39.12 38.08 38.081
EV/Revenue 348.44 60.18 48.86 29.59 20.37 14.08 14.38 9.74 12.53 16.87 16.92 16.923
EV/EBIT -24.65 -15.88 -16.50 -11.96 -10.74 -10.27 -11.63 -13.13 -20.01 -22.51 -34.01 -98.55 425.99 67.87 39.65 35.91 23.05 28.37 40.71 39.50 39.496
EV/FCF -23.85 -12.91 -9.66 -9.07 -6.84 -7.22 -10.77 -11.08 -21.26 -25.04 -30.33 -86.11 -216.13 84.72 34.33 37.08 18.87 28.24 34.75 29.75 29.750
Earnings Yield -3.5% -5.0% -4.5% -6.2% -6.9% -7.3% -6.9% -6.6% -4.5% -0.9% 0.3% 1.1% 1.9% 1.0% 1.9% 2.3% 3.6% 3.8% 2.8% 2.9% 2.86%
FCF Yield -3.5% -6.0% -7.5% -8.2% -10.9% -10.5% -7.6% -7.4% -4.1% -3.6% -2.8% -1.0% -0.4% 1.1% 2.5% 2.4% 4.5% 3.1% 2.6% 3.0% 3.01%
PEG Ratio snapshot only 0.488
Price/Tangible Book snapshot only 6.462
EV/OCF snapshot only 28.217
EV/Gross Profit snapshot only 18.237
Acquirers Multiple snapshot only 39.496
Shareholder Yield snapshot only 0.22%
Graham Number snapshot only $81.45
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 17.80 17.80 17.18 17.18 17.18 17.18 13.30 13.30 13.30 13.30 17.76 17.76 17.76 17.76 7.28 7.28 7.28 7.28 9.95 9.95 9.953
Quick Ratio 17.80 17.80 17.18 17.18 17.18 17.18 13.30 13.30 13.30 13.30 17.55 17.55 17.55 17.55 7.02 7.02 7.02 7.02 9.56 9.56 9.560
Debt/Equity 0.04 0.04 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.008
Net Debt/Equity -0.89 -0.89 -0.72 -0.72 -0.72 -0.72 -0.71 -0.71 -0.71 -0.71 -0.67 -0.67 -0.67 -0.67 -0.62 -0.62 -0.62 -0.62 -0.67 -0.67 -0.671
Debt/Assets 0.04 0.04 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.007
Debt/EBITDA -0.24 -0.21 -0.12 -0.08 -0.07 -0.06 -0.06 -0.07 -0.07 -0.07 -0.10 -0.19 0.45 0.10 0.07 0.05 0.05 0.04 0.06 0.05 0.050
Net Debt/EBITDA 5.35 4.79 6.59 4.28 3.82 3.35 2.68 2.98 2.78 2.91 6.24 12.60 -29.04 -6.62 -5.37 -4.21 -3.73 -3.45 -4.88 -4.41 -4.413
Interest Coverage -33.99 -38.00 -45.63
Equity Multiplier 1.06 1.06 1.06 1.06 1.06 1.06 1.07 1.07 1.07 1.07 1.05 1.05 1.05 1.05 1.12 1.12 1.12 1.12 1.09 1.09 1.094
Cash Ratio snapshot only 8.041
Cash to Debt snapshot only 88.638
FCF to Debt snapshot only 25.418
Defensive Interval snapshot only 1672.8 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.07 0.14 0.24 0.35 0.31 0.36 0.38 0.40 0.33 0.35 0.349
Inventory Turnover 1.32 2.01 3.73 5.58 1.20 1.35 1.42 1.36 0.86 0.90 0.898
Receivables Turnover 2.41 4.56 7.91 11.49 3.96 4.54 4.89 5.08 3.35 3.59 3.595
Payables Turnover 0.00 0.00 0.00 0.19 0.19 0.19 0.16 0.00 0.00 0.04 1.58 2.41 4.47 6.69 5.87 6.63 6.97 6.67 7.00 7.31 7.313
DSO 0 151 80 46 32 92 80 75 72 109 102 101.5 days
DIO 0 0 0 0 0 277 182 98 65 305 270 257 268 425 407 406.6 days
DPO 1888 1888 1888 2226 10131 231 152 82 55 62 55 52 55 52 50 49.9 days
Cash Conversion Cycle -10131 197 110 62 43 335 295 279 285 482 458 458.2 days
Fixed Asset Turnover snapshot only 2.641
Operating Cycle snapshot only 508.1 days
Cash Velocity snapshot only 0.504
Capital Intensity snapshot only 3.196
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 27.2% 4.7% 2.5% 1.2% 54.5% 33.9% 25.1% 25.15%
Net Income -1.4% -1.1% -1.2% -1.4% -1.2% -1.2% -1.0% -30.5% -21.6% 77.0% 1.1% 1.4% 1.8% 2.8% 7.2% 1.2% 38.5% 2.8% 1.3% 81.5% 81.53%
EPS -98.1% -89.8% -95.0% -1.1% -92.4% -93.4% -74.8% -27.4% -16.5% 79.6% 1.1% 1.4% 1.7% 2.7% 6.9% 1.1% 38.0% 2.8% 1.3% 77.7% 77.75%
FCF -77.8% -99.1% -1.8% -2.0% -2.5% -1.7% -32.1% -11.4% 28.8% 36.6% 34.5% 64.3% 82.5% 1.5% 2.2% 3.4% 9.1% 1.9% 58.5% 83.6% 83.56%
EBITDA -1.2% -1.1% -1.2% -1.6% -1.3% -1.4% -1.1% -23.6% -18.2% 0.8% 39.2% 66.5% 1.1% 1.6% 2.3% 4.4% 7.8% 1.2% 52.7% 32.2% 32.19%
Op. Income -1.1% -97.7% -1.1% -91.1% -80.0% -88.9% -76.1% -81.7% -67.3% -37.6% 8.7% 53.0% 86.3% 1.2% 1.6% 2.6% 7.6% 4.8% 1.5% 64.7% 64.72%
OCF Growth snapshot only 80.70%
Asset Growth snapshot only 26.33%
Equity Growth snapshot only 28.87%
Debt Growth snapshot only 28.62%
Shares Change snapshot only 2.13%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y
Revenue 5Y 75.3% 1.0% 1.2% 1.3% 1.6% 2.0% 2.6%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y 74.4% 97.2% 1.1% 1.3% 1.5% 2.0% 2.6%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 83.7% 83.7% 75.4% 75.4% 75.4% 75.4% 38.8% 38.8% 38.8% 38.8% 38.1% 38.1% 38.1% 38.1% 19.0% 19.0% 19.0% 19.0% 33.7% 33.7% 33.67%
Assets 5Y 2.1% 62.0% 62.0% 62.0% 62.0% 47.8% 47.8% 47.8% 47.8% 38.3% 38.3% 38.3% 38.3% 33.8% 33.8% 33.82%
Equity 3Y 80.7% 80.7% 73.7% 73.7% 73.7% 73.7% 37.0% 37.0% 37.0% 37.0% 38.7% 38.7% 38.7% 38.7% 16.8% 16.8% 16.8% 16.8% 32.7% 32.7% 32.67%
Book Value 3Y 40.0% 41.3% 47.4% 44.4% 43.9% 52.4% 20.4% 20.2% 21.1% 20.6% 22.8% 24.6% 25.9% 25.6% 5.8% 10.3% 11.0% 11.0% 25.8% 25.3% 25.32%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.14 0.22 0.89 0.80 0.60 0.05 0.05 0.19 0.66 0.36 0.38 0.39 0.40 0.42 0.52 0.58 0.65 0.70 0.76 0.80 0.800
Earnings Stability 0.81 0.86 0.84 0.79 0.80 0.77 0.80 0.87 0.88 0.32 0.08 0.00 0.01 0.06 0.17 0.29 0.35 0.54 0.63 0.72 0.718
Margin Stability 0.96 0.95 0.96 0.97 0.99 1.00 0.997
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.88 0.91 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.00 0.26 0.68 0.00 0.21 0.42 0.421
ROE Trend -0.05 -0.06 -0.02 -0.05 -0.05 -0.05 -0.15 -0.10 -0.08 0.15 0.21 0.29 0.37 0.21 0.22 0.22 0.22 0.21 0.11 0.08 0.082
Gross Margin Trend -0.01 0.01 -0.00 -0.001
FCF Margin Trend 7.28 1.27 0.66 0.659
Sustainable Growth Rate 1.7% 8.8% 16.3% 8.1% 10.3% 14.4% 17.0% 23.1% 18.9% 20.8% 20.78%
Internal Growth Rate 1.6% 9.1% 18.2% 8.2% 10.5% 15.2% 18.6% 26.9% 20.7% 23.2% 23.20%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.66 0.60 0.69 0.52 0.75 0.76 0.72 0.82 0.73 3.49 -8.12 -0.82 -0.16 1.21 1.38 1.12 1.33 0.89 0.98 1.11 1.112
FCF/OCF 1.52 1.99 2.43 2.54 2.10 1.89 1.53 1.37 1.27 1.15 1.13 1.16 1.36 0.92 0.97 0.93 0.95 0.94 0.94 0.95 0.948
FCF/Net Income snapshot only 1.055
OCF/EBITDA snapshot only 1.350
CapEx/Revenue 1.8% 23.3% 8.0% 3.6% 2.2% 1.5% 2.8% 2.8% 2.8% 3.1% 3.1% 3.09%
CapEx/Depreciation snapshot only 1.941
Accruals Ratio -0.07 -0.09 -0.05 -0.11 -0.06 -0.07 -0.07 -0.04 -0.06 0.13 0.14 0.15 0.18 -0.02 -0.04 -0.02 -0.05 0.02 0.00 -0.02 -0.021
Sloan Accruals snapshot only 0.230
Cash Flow Adequacy snapshot only 19.409
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 7.5% 7.54%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.22%
Net Buyback Yield -10.1% -13.3% -22.9% -12.2% -14.0% -13.2% -1.8% -1.9% -6.2% -5.7% -5.3% -3.6% -0.0% -0.0% 0.0% 0.0% -0.0% -0.1% -0.3% -0.1% -0.14%
Total Shareholder Return -10.1% -13.3% -22.9% -12.2% -14.0% -13.2% -1.8% -1.9% -6.2% -5.7% -5.3% -3.6% -0.0% -0.0% 0.0% 0.0% -0.0% -0.1% -0.3% -0.1% -0.14%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.85 0.97 0.98 0.91 0.94 0.90 0.87 1.06 1.08 1.09 1.085
Interest Burden (EBT/EBIT) 1.03 1.03 1.02 1.00 0.99 0.98 0.98 1.05 1.02 0.23 -0.14 -1.24 9.39 0.79 0.92 1.03 1.11 1.13 1.17 1.16 1.159
EBIT Margin -15.48 -1.77 -0.50 0.07 0.30 0.36 0.40 0.42 0.44 0.41 0.43 0.428
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.07 0.14 0.24 0.35 0.31 0.36 0.38 0.40 0.33 0.35 0.349
Equity Multiplier 1.05 1.05 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.09 1.09 1.09 1.09 1.10 1.10 1.103
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.35 $-2.62 $-3.13 $-4.13 $-4.52 $-5.06 $-5.48 $-5.26 $-5.27 $-1.03 $0.38 $1.95 $3.57 $1.75 $2.98 $4.15 $4.93 $6.67 $6.84 $7.38 $7.38
Book Value/Share $13.15 $13.15 $26.73 $23.63 $23.24 $23.17 $20.44 $20.31 $19.59 $18.08 $27.02 $26.58 $26.27 $26.04 $31.67 $31.68 $31.81 $31.72 $40.72 $39.98 $43.59
Tangible Book/Share $13.15 $13.15 $26.73 $23.63 $23.24 $23.17 $20.44 $20.31 $19.59 $18.08 $27.02 $26.58 $26.27 $26.04 $31.67 $31.68 $31.81 $31.72 $40.72 $39.98 $39.98
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.30 $1.76 $3.28 $5.61 $8.08 $9.72 $11.16 $12.07 $12.51 $12.99 $13.68 $14.25
FCF/Share $-2.36 $-3.14 $-5.24 $-5.45 $-7.14 $-7.33 $-6.01 $-5.93 $-4.87 $-4.12 $-3.49 $-1.86 $-0.77 $1.94 $3.99 $4.33 $6.23 $5.55 $6.31 $7.78 $8.11
OCF/Share $-1.56 $-1.58 $-2.16 $-2.14 $-3.39 $-3.87 $-3.94 $-4.33 $-3.84 $-3.60 $-3.08 $-1.60 $-0.56 $2.12 $4.13 $4.64 $6.57 $5.91 $6.71 $8.20 $8.55
Cash/Share $12.22 $12.21 $19.73 $17.44 $17.15 $17.10 $14.84 $14.75 $14.22 $13.12 $18.47 $18.17 $17.96 $17.80 $20.00 $20.00 $20.09 $20.03 $27.64 $27.13 $28.11
EBITDA/Share $-2.19 $-2.44 $-2.94 $-4.00 $-4.41 $-5.01 $-5.41 $-4.83 $-4.99 $-4.40 $-2.92 $-1.42 $0.61 $2.65 $3.68 $4.70 $5.31 $5.74 $5.60 $6.08 $6.08
Debt/Share $0.52 $0.52 $0.36 $0.32 $0.31 $0.31 $0.35 $0.35 $0.34 $0.31 $0.28 $0.28 $0.27 $0.27 $0.24 $0.24 $0.24 $0.24 $0.31 $0.31 $0.31
Net Debt/Share $-11.70 $-11.69 $-19.37 $-17.12 $-16.84 $-16.79 $-14.49 $-14.40 $-13.89 $-12.81 $-18.19 $-17.89 $-17.68 $-17.53 $-19.75 $-19.76 $-19.84 $-19.79 $-27.33 $-26.83 $-26.83
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 43.002
Altman Z-Prime snapshot only 77.928
Piotroski F-Score 2 2 2 2 2 2 1 1 1 2 5 5 5 7 7 6 7 7 6 8 8
Beneish M-Score 8.66 -0.98 -0.94 -1.17 -0.78 -2.29 -2.37 -2.367
Ohlson O-Score snapshot only -14.896
ROIC (Greenblatt) snapshot only 16.56%
Net-Net WC snapshot only $29.84
EVA snapshot only $153974264.39
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA+
Credit Score 60.96 61.06 61.06 74.77 75.45 75.48 76.78 76.20 76.41 76.48 76.71 76.44 76.56 94.35 94.62 94.51 94.43 94.08 94.41 94.24 94.245
Credit Grade snapshot only 2
Credit Trend snapshot only -0.266
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 93
Sector Credit Rank snapshot only 88

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms